Antioxidant treatment reverses mitochondrial dysfunction in a sepsis animal model
- 1 June 2008
- journal article
- research article
- Published by Elsevier in Mitochondrion
- Vol. 8 (3) , 211-218
- https://doi.org/10.1016/j.mito.2008.03.002
Abstract
No abstract availableKeywords
This publication has 57 references indexed in Scilit:
- Role of nitric oxide in the expression of hepatic vascular stress genes in response to sepsisNitric Oxide, 2007
- Metabolic insights into the hepatoprotective role of N-acetylcysteine in mouse liverHepatology, 2006
- A Mitochondrial Paradigm of Metabolic and Degenerative Diseases, Aging, and Cancer: A Dawn for Evolutionary MedicineAnnual Review of Genetics, 2005
- Mitochondrial nitric oxide metabolism in rat muscle during endotoxemiaFree Radical Biology & Medicine, 2004
- Multiple-center, randomized, placebo-controlled, double-blind study of the nitric oxide synthase inhibitor 546C88: Effect on survival in patients with septic shock*Critical Care Medicine, 2004
- The Pathophysiology and Treatment of SepsisNew England Journal of Medicine, 2003
- Therapeutic potential of superoxide dismutase mimetics as therapeutic agents in critical care medicineCritical Care Medicine, 2003
- Deferoxamine reduces tissue injury and lethality in LPS-treated miceInternational Journal of Immunopharmacology, 2000
- Defining the role of oxyradicals in the pathogenesis of sepsisCritical Care Medicine, 1995
- N-Acetylcysteine and glutathione as inhibitors of tumor necrosis factor productionCellular Immunology, 1992